SOURCE: TheraBiogen, inc.

  Jan 18, 2011 09:00 ET

NEW YORK, NY–(Marketwire – January 18, 2011) –  TheraBiogen, inc. (OTCBB: TRAB) announced it has shipped TheraMax® to Hannaford Supermarket and Sweetbay Supermarket.

TheraBiogen, inc.: TheraBiogen the developer and distributor of TheraMax® nasal spray products, is pleased to announce that TheraMax® Cold & Flu Relief and TheraMax® Allergy Relief are now being sold at all the Hannaford Supermarkets. Hannaford stores are located in Maine, New Hampshire, Vermont, Massachusetts, and New York. Sweetbay Supermarket located entirely in Florida, the sister company of Hannaford Bros., is also carrying both TheraMax® products. TheraMax® products are Homeopathic Nasal sprays that do not contain Zinc. 

TheraBiogen has been selling TheraMax® Cold & Flu Relief and TheraMax® Allergy Relief since the beginning of the 2010 Fall Season for cold and flu relief. Consumers nationwide have embraced the new products since their initial launch in October 2010. Kelly Hickel, CEO of TheraBiogen, inc., said “We are very pleased that Hannaford has chosen to add our products to their stores and add to our market distribution of TheraMax® Cold & Flu Relief and TheraMax® Allergy Relief.”

About TheraBiogen, inc. TheraBiogen, inc. is the manufacturer and distributor of homeopathic nasal sprays for aiding in the relief of allergies and cold and flu symptoms. The products are made from natural, homeopathic ingredients and contain no zinc, which has been identified as potentially causing  nasal problems in other similar products on the market. for further information please visit theramaxrelief.com.

Safe Harbor Statement This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21 E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that these forward-looking statements involve uncertainties and risk that could cause actual performance and results of operations to differ materially from those anticipated. These risks are set forth in the Company’s most recently filed form 10-K and Form 10-Q reports. TheraBiogen, inc. assumes no obligation to update the statements contained in this release except as required by applicable securities disclosure rules.